Original Article

Evaluation of Antidiabetic Prescriptions from Medical Reimbursement Applications at Banaras Hindu University Health Care Facility


Background: Diabetes is on rapid increase in third world countries undergoing rapid transition in terms of development particularly in India, which is often being referred as Diabetic capital. It is a disease more prevalent at latter part of life of human beings when finances dwindle and social care gets neglected. The medication continues till the whole life on a regular basis. In present study, the objective has been to provide pharmacoeconomic medication to the diabetic pensioners in the backdrop as mentioned in above background.
Methods: The data was collected at the medical reimbursement section of pensioners of the University. The data was examined to answer issues of therapeutic decisions in the light of the pharmacoeconomic considerations. In this paper essentially data on choice of prescriptions with the angle of pharmacoeconomic prudence were included. The dichotomy of specialist versus non specialist prescribers at the tertiary center (i.e. medical college hospital) was compared. Effort was made to define merit of the prescription based on comprehensive considerations of patient profile, disease profile and therapeutic choice.
Results: Total 72 prescriptions were analyzed for the study in which 475 drugs were prescribed to the patients.  Total antidiabetic drugs prescribed to the patients were 169. Out of 72 cases 39 were males and 33 were females with mean age 66.04 ± 5.80 (Mean ± SEM). The average number of drugs per prescription was 6.59 which was very high as per guidelines. Most commonly prescribed antidiabetic drug was Metformin (63.89%) followed by Glimepiride (31.95%).
Conclusion: This study reflects that there is need to make available the standard therapeutic optionat University Health Care Facility based upon pharmacoeconomic considerations.

Fox Rushby J and Cairns J. “Economic Evaluation”, Open University Press, 2005.

Finder S. Providing Cost Effective Therapy Using Pharmacoeconomic Evaluations: The Public Sector Approach. Clin Ther 1997; 19(1): 160-2.

Bottomley JM. Pharmacoeconomic issues for Diabetes therapy. Best Pract Res Clin Endocrinol Metab 2007; 21(4):657-85.

Bootman JL, Townsend RJ , McGhan WF. Text Book of Principles of Pharmacoeconomics. 2nd edition, Harvey Whitney Books, Cincinnati Ohio, 1996, 1-98.

Enright S. Hospital Pharmacy. Am Med J 1983; 40: 83.

World Health Organization’s Task force on Health Economics and Health Sector Reform report (WHO-TF/HE/HSR/75), 1996, 1-56.

Ahuja J, Gupta M, Gupta AK, et al. Pharmacoeconomics. Natl Med J India 2004; 17 (2):80-3.

WHO/NCD/NCS/99.2; Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. National Diabetic Group, 1979.

Misra B, Jain SK, Mehta Y. A study on availability and prices of medicines in India. National Pharmaceutical Pricing Authority, 2002. Available from: http://nppaindia.nic.in/index1.html.

Das P, Das BP, Rauniar GP, Roy RK, Sharma SK. Drug utilization pattern and effectiveness analysis in Diabetes mellitus at a tertiary care center in Eastern Nepal. Indian J Physiol Pharmacol 2011; 55(3): 272-80.

Loganathan ACV, John KR. Economic burden of diabetes in people living with the disease: A field study. Journal of Diabetology 2013; 3(4):1-8.

Chanana HB, Talwar PP. Aging in India: Its Socio-economic and health implications. Asia Pac Popul J 1987; 2:23–38.

Zaveri HG, Mansuri SM, Patel VJ. Use of potentially inappropriate medicine in elderly: A prospective study in medicine outpatient department of a tertiary care teaching hospital. Indian J Pharmacol 2010; 42:95–8.

Klotz U. Pharmacokinetics and drug metabolism in the elderly. Drug Metabol Rev 2009; 41: 67–76.

Gorzoni ML, Fabbri RM, Pires SL. Potentially inappropriate medications in elderly. Revista da Associacao Medica Brasileira 2012; 58: 442–6.

Oslo: World Health Organization; 2003; “Introduction to drug utilization research”.

Fulton MM, Allen ER. Polypharmacy in the elderly: a literature review. J Am Acad Nurse Pract 2005; 17:123–32.

Frazier SC. Health outcomes and polypharmacy in elderly individuals: an integrated literature review. J Gerontol Nurs 2005; 31: 4–11.

Bjerrum L, Rosholm JU, Hallas J, Kragstrup J. Methods for estimating the occurrence of polypharmacy by means of a prescription database. Eur J Clin Pharmacol 1997; 53:7–11.

Kumar MA, Nizar A, Shailaja K, Jayasutha J, Ramasamy C.A study on prescribing pattern and potentials drug-drug interactions in type-2 diabetes mellitus(inpatients) in a tertiary care teaching hospitals. Der Pharmacia Lettre 2011; 3 (4):13-19.

Jhaveri BN, Patel TK, Barvaliya MJ, Tripathi CB. Drug utilization pattern and pharmacoeconomic analysis in geriatric medical in-patients of a tertiary care hospital of India. J Pharmacol Pharmacother 2014; 5(1):15-20.

Abidi A, Gupta S, Kansal S. Prescription auditing and drug utilization pattern in a tertiary care teaching hospital of western UP. Int J Basic Clin Pharmacol 2012; 1(3):184-190.

Acharya KG, Shah KN, Solanki ND, Rana DA. Evaluation of antidiabetic prescriptions, cost and adherence to treatment guidelines: A prospective,cross-sectional study at a tertiary care teaching hospital. J Basic Clin Pharmacy 2013; 4(4):82-7.

IssueVol 2, No 2 (Spring 2014) QRcode
SectionOriginal Article(s)
Fee-for-Service Plans Antidiabetic drugs Pharmacoeconomics

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
Priya D, Purohit S, Pandey B, Mishra S. Evaluation of Antidiabetic Prescriptions from Medical Reimbursement Applications at Banaras Hindu University Health Care Facility. J Pharm Care. 2(2):49-54.